BRADLEY TYMCHUK: Open Payments
NPI 1437503380 · HERMISTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 18 payments from 12 companies in 2025. Trend: 2023 $234 · 2024 $266 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Novo Nordisk Inc | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Medtronic, Inc. | 2 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: JARDIANCE, SHINGRIX, RELISTOR, Ozempic, MINIMED 780G, STRENSIQ, GEMTESA, GVOKE HYPOPEN.
Industry payments across OR — which companies pay providers there.
